Clinical data of the control and CoA cases in our cohort. by Inmaculada Villanueva-Baxarias (21454246)

Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

“…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”

Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

“…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”

Deaths and ASMR of AA^a due to Hypertension in 1990 and 2021, along with the EAPC from 1990 to 2021. by Guanghui Yu (423945)

The trends in ASDR of hypertension-related AA by sex from 2022 to 2050 using the BAPC (A) Female; (B) Male. by Guanghui Yu (423945)

S1 File - Effectiveness of a school-based physical activity intervention on overweight and obesity among children and adolescents in Pakistan by Moazzam Tanveer (20775814)

Comparison of ν_s measured and predicted estimates of the optimized GPR approach for (a) training, (b) validation, and (c) testing datasets. by Fahd Saeed Alakbari (10701871)

Original data (a, b, c, d) and disproportionality analysis results (ROR & IC). by Mengsi Peng (12882734)

SEM images (a) 5LZCM (b) 10LZCM (c) 15LZCM. by Md. Abu Daud (21485629)

Data. by Aroon La-up (14095691)

“…This study found a statistically significant decrease in BMD in the group with the lowest U-Cd levels (<2.0 μg/g creatinine, p = 0.001) and in the overall sample (from 0.392 ± 0.079 μg/g creatinine in 2019 to 0.384 ± 0.094 μg/g creatinine in 2022, p = 0.004). …”

Forest plot showing the ratio of odds of acute side effects: nausea (a) and vomiting (b) (=events) among pediatric patients with brain tumors treated with PT or XRT. by Renáta Kiss-Miki (20760127)

Morphologic changes after dihydrotestosterone (DHT) treatment.1A: Diffuse lobular atrophy (20x). by Jinho Lee (587173)

A set of 4 criteria for the needs of multi-criteria evaluation ‐ combinations B1– B5. by Roman Vavrek (13200141)

A set of 3 criteria for the needs of multi-criteria evaluation ‐ combinations C1–C10. by Roman Vavrek (13200141)

A set of 2 criteria for the needs of multi-criteria evaluation ‐ combinations D1–D10. by Roman Vavrek (13200141)

The PP1/PP2A inhibitor calyculin A increases phosphorylated Ser295 of PSD-95 concomitantly with the activation of JNK1. by Takahiko Chimura (729098)

Non-linear relationship between urinary cadmium and bone mineral density from the adjusted restricted cubic splines model. by Aroon La-up (14095691)

Overall CVD disease burden in DALYs attributable to 1^st-level risk factors in Chile. DALYs rates are expressed per 100,000 individuals, with a 95% uncertainty interval. by Camilo Briones-Valdivieso (21567535)

Determinants of institutional delivery for women who had a live birth one year before the survey, NDHS 2022. by Resham B. Khatri (10949429)

Demographics of the study population. by Sohyun Park (78358)

“…OBH was a significant independent predictor of iPD, with a cutoff of 1.52 mm. …”